N
Nexgel Inc (NXGL)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
$3.93
+0.05 (+1.29%)
Market Cap: $2.08M
Last updated: Nov 17, 2026 at 10:58 AM ET
Nexgel Inc (NXGL) Valuation Multiples
Nexgel (NXGL) trades at 0.2x sales and 0.5x book value. Its P/S of 0.2x is below its 5-year median of 63.4x. Its forward P/E is 1.4x.
Current Multiples
Its enterprise value is 1.3x its EBITDA.
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 1.4x |
| Price to sales | 0.2x |
| Price to book | 0.5x |
| EV/EBITDA | 1.3x |
| PEG | N/A |
| FCF yield | -193.6% |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 0.2x | 63.4x | N/A |
| P/B | 0.5x | 42.5x | N/A |
Valuation History
Over the 5 year ends shown, its P/S ranged from 20.0x in 2025 to 117.9x in 2021. 2025 was the lowest of those years.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $32.20 | 20.0x | 56.7x |
| 2024 | $89.20 | 68.3x | 113.2x |
| 2023 | $42.60 | 59.2x | 52.1x |
| 2022 | $25.00 | 68.0x | 18.3x |
| 2021 | $52.20 | 117.9x | 24.0x |
Frequently Asked Questions About NXGL
What is NXGL's forward P/E ratio?
Nexgel has a forward P/E ratio of 1.4x.
What is NXGL's price to sales ratio?
Nexgel has a price to sales ratio of 0.2x.
NXGL pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors